帮忙把下文 (论文中的中文摘要翻译成英文吧,或者是提供一下什么地方可以提供翻译)谢谢
慢性心力衰竭(CHF)是一种复杂的血流动力学、神经内分泌代谢紊乱的临床综合症。是各种心脏病的严重阶段。脂联素(APN)是由白色脂肪细胞特异性分泌的一种脂肪细胞因子,多种研...
慢性心力衰竭(CHF)是一种复杂的血流动力学、神经内分泌代谢紊乱的临床综合症。是各种心脏病的严重阶段。脂联素(APN)是由白色脂肪细胞特异性分泌的一种脂肪细胞因子,多种研究显示脂联素参与了心力衰竭的发生,进展,愈后,参与了神经内分泌的激活,但其具体作用机制和环节尚不十分清楚。因此研究脂联素(APN)在心衰中的作用机制成为当前的热点,本文参阅了近年来的有关临床研究结果,显示多数临床结果为血清脂联素水平可以随着心力衰竭患者心功能不全分级的递增而明显升高,少数临床研究显示相反的结果,冠心病心力衰竭患者根据冠心病分类不同呈动态变化。监测血清脂联素的变化趋势可能有助于预测心力衰竭患者的心衰发生及评价心力衰竭患者的治疗效果。该文就慢性心力衰竭(CHF)与脂联素(APN)研究现状做一综述。
展开
展开全部
Chronic heart failure (CHF) is a complex hemodynamic, metabolic disorders clinical neuroendocrine syndrome. The serious stage of various heart diseases. Adiponectin (APN) is secreted from white fat cells of a fat cell specific factor, many studies have shown that adiponectin involved in heart failure, progression, prognosis, involved in neuroendocrine activation, but their specific mechanisms and links is not very clear. Therefore study of adiponectin (APN) role in the mechanism of heart failure has become the hot spot, see a recent paper on clinical studies, clinical results show the majority of serum adiponectin levels can be with the sub-ventricular dysfunction in patients with heart failure significantly higher level of progression, a few clinical studies have shown the opposite result, coronary heart disease coronary heart disease classified according to different heart failure patients showed dynamic changes. Monitoring of serum adiponectin may help predict trends in heart failure patients with heart failure and evaluation of treatment of patients with heart failure. The article on chronic heart failure (CHF) and adiponectin (APN) Research were reviewed.
推荐律师服务:
若未解决您的问题,请您详细描述您的问题,通过百度律临进行免费专业咨询